Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, BioAnalytix to Develop Platforms, Applications for Biologics Characterization

NEW YORK (GenomeWeb) – Thermo Fisher Scientific and BioAnalytix today announced they will develop advanced analytical profiling platforms and applications for characterizing biologic and biosimilar drugs.

Minor differences in the structures of biological drugs can significantly affect their safety and efficacy, and sophisticated analytic workflows are necessary for accurate characterization. Thermo Fisher and BioAnalytix aim to develop analytical profiling standards in order to support and accelerate the development of such therapeutics, they said.

As part of the effort, researchers at BioAnalytix will use Thermo Fisher's Orbitrap-based mass spectrometers, sample preparation, separation and enrichment standards, reagents, and software, the firms said.

Financial and other terms of the deal were not disclosed.

Based in Cambridge, Mass., BioAnalytix was spun out from the Barnett Institute of Chemical and Biological Analysis at Northeastern University in 2012 and works with pharmaceutical firms to develop and apply analytical methods and data for the development of biologic therapeutics.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.